Back

Blood pressure lowering treatment for prevention of cardiovascular diseases in people with and without chronic kidney disease: an individual participant-level data meta-analysis

30 August 2025 (17:15 - 18:00)
Organised by: Logo
Congress Presentation Part of: Therapeutic approaches to hypertension and its comorbidities Clinical ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Ms Guyu Zeng

Beijing (China)

3 More presentations in this session

Presentation thumbnail
The effect of a selective urate reabsorption inhibitor dotinurad on uric acid and renal function in patients with hyperuricemia and hypertension.
Doctor T. Mizoguchi (Nagoya, JP)
Abstract Slides Video
Presentation thumbnail
App-based multimodal lifestyle-intervention for essential hypertension: a randomized-controlled, decentralized trial in Germany
Professor F. Limbourg (Hannover, DE)
Abstract Slides Video
Presentation thumbnail
Impact of plateau on antihypertensive efficacy among hypertensive highlanders : a post hoc analysis of the OMAN Trial
Doctor X. Zuo (Sichuan, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Therapeutic approaches to hypertension and its comorbidities

The Event

Event poster

ESC Congress 2025

30 August 2025 17:15 CET
You may be interested in
thumbnail
Congress Presentation
Short-term effects of blood pressure lowering drugs on cardiovascular events: a systematic review and meta-analysis of randomised, placebo-controlled, doubled-blind trials
thumbnail
Congress Presentation
People with CKD in cardiovascular trials: a neglected population? A systematic review and evidence map
thumbnail
Congress Session
Strategies for prevention and better outcomes in chronic kidney disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources